These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 22570936)
1. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine. Zhou L; Chen Y; Zhang Z; He J; Du M; Wu Q Pharmazie; 2012 Apr; 67(4):304-10. PubMed ID: 22570936 [TBL] [Abstract][Full Text] [Related]
2. Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine. Chen Y; Yuan L; Zhou L; Zhang ZH; Cao W; Wu Q Int J Nanomedicine; 2012; 7():4581-91. PubMed ID: 22942642 [TBL] [Abstract][Full Text] [Related]
3. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers. Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398 [TBL] [Abstract][Full Text] [Related]
4. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
5. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and Wu L; Zhao L; Su X; Zhang P; Ling G Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898 [TBL] [Abstract][Full Text] [Related]
6. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758 [TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445 [TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects. Chen X; Zhang Y; Zhao P; Chen Y; Zhou Y; Wang S; Yin L Drug Dev Ind Pharm; 2020 Jan; 46(1):57-69. PubMed ID: 31813288 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Dudhipala N; Janga KY; Gorre T Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077 [TBL] [Abstract][Full Text] [Related]
10. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Kawadkar J; Pathak A; Kishore R; Chauhan MK Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934 [TBL] [Abstract][Full Text] [Related]
11. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies. Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494 [TBL] [Abstract][Full Text] [Related]
12. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation. Shehata MK; Ismail AA; Kamel MA Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692 [TBL] [Abstract][Full Text] [Related]
13. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Chen-yu G; Chun-fen Y; Qi-lu L; Qi T; Yan-wei X; Wei-na L; Guang-xi Z Int J Pharm; 2012 Jul; 430(1-2):292-8. PubMed ID: 22486962 [TBL] [Abstract][Full Text] [Related]
14. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556 [No Abstract] [Full Text] [Related]
15. SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma. Shirazi AS; Varshochian R; Rezaei M; Ardakani YH; Dinarvand R J Mater Sci Mater Med; 2021 Jun; 32(7):78. PubMed ID: 34191134 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model. Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831 [TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers as a delivery system of biochanin A. Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability. Teng Z; Yu M; Ding Y; Zhang H; Shen Y; Jiang M; Liu P; Opoku-Damoah Y; Webster TJ; Zhou J Int J Nanomedicine; 2019; 14():119-133. PubMed ID: 30613141 [TBL] [Abstract][Full Text] [Related]
19. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers. Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361 [TBL] [Abstract][Full Text] [Related]
20. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study. Zafar A J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]